Stock Information

Keros Therapeutics Inc (KROS)

Keros Therapeutics Inc logo
Ticker Symbol: KROS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $365.59 mil
Piotroski score: 3
PE Ratio: 2.6535
EPS (TTM): 1.8178
Revenue (TTM): $9.01 M
Dividend Yield: N/A%
ROE: 14.25%

Latest News

Key Financials

Financial data not available